英文字典,中文字典,查询,解释,review.php


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       


安装中文字典英文字典辞典工具!

安装中文字典英文字典辞典工具!










  • American College of Rheumatology
    We would like to show you a description here but the site won’t allow us
  • PATIENT FACT SHEET Bisphosphonate Therapy - arshclinic. com
    © 2017 American College of Rheumatology PATIENT FACT SHEET www ACRPatientInfo org WHAT IS IT? TELL YOUR DOCTOR Bisphosphonates are a group of medicines used to treat bone problems, such as thin or fragile bones These medications are given to patients with abnormal bone density scans or to patients with a history of
  • Bisphosphonates Reduce Bone Toughness Over Time
    Treatment with bisphosphonates for one to three years increases bone mineral density (BMD), strength and stiffness of lumbar vertebrae in compression but has little effect on the properties of diaphyseal bone
  • Patterns of Use of Long-Term ( gt; 5 Years) Oral Bisphophonate . . .
    The diagnosis was osteoporosis in 54%, osteopenia in 21%, and not documented in 23% The most commonly prescribed bisphosphonate was alendronate (71%) The duration of bisphosphonate therapy ranged from 5 to 14 years (mean 8 years)
  • Bisphosphonate Therapy - Rheumatology for Primary Care
    ACR Education Center; Rheumatology Provider Directory; Bisphosphonate Therapy Home » Bisphosphonate Therapy Primary Care 2024-04-08T22:50:29+00:00 American College of Rheumatology Information About ACR ACR Contacts Authors This product was funded by a medical grant from Pfizer The content was written by a physician work group
  • 2017 American College of Rheumatology Guideline for the . . . - PubMed
    The guideline addresses initial assessment and reassessment in patients beginning or continuing long-term (≥3 months) glucocorticoid (GC) treatment, as well as the relative benefits and harms of lifestyle modification and of calcium, vitamin D, bisphosphonate, raloxifene, teriparatide, and denosumab treatment in the general adult population
  • 2017 American College of Rheumatology Guideline for the Prevention and . . .
    Our main concern is that in adults at high risk for fracture, oral and then parenteral bisphosphonates are recommended over teriparatide in selecting drug ther-apy This recommendation represents a departure from the 2010 ACR GIOP guideline (2), which avoided rating bisphos-phonates (either oral or parenteral) preferentially over teri-paratide
  • Bisphosphonates are a group of medicines used to treat IV - AchyJoint
    © 2018 American College of Rheumatology PATIENT FACT SHEET www ACRPatientInfo org WHAT IS IT? TELL YOUR DOCTOR Bisphosphonates are a group of medicines used to treat bone problems, such as thin or fragile bones These medications are given to patients with abnormal bone densities or to patients with a history of abnormal bone


















中文字典-英文字典  2005-2009